Viemed Healthcare (VMD)
(Delayed Data from NSDQ)
$7.33 USD
-0.07 (-0.95%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $7.32 -0.01 (-0.14%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
VMD 7.33 -0.07(-0.95%)
Will VMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VMD
Viemed Healthcare, Inc. (VMD) Misses Q1 Earnings Estimates
Pediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue Beat
VMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
BellRing Brands Inc. (BRBR) Hit a 52 Week High, Can the Run Continue?
LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Beat Estimates
Viemed Healthcare, Inc. (VMD) is on the Move, Here's Why the Trend Could be Sustainable
Other News for VMD
Viemed Healthcare Unveils Investor Deck for Stakeholder Insights
Lake Street Releases a Buy Rating on Viemed Healthcare (VMD)
Viemed Healthcare, Inc. (VMD) Q2 2024 Earnings Call Transcript
Viemed Healthcare Announces Record Second Quarter 2024 Financial Results
VMD Stock Earnings: Viemed Healthcare Misses EPS, Misses Revenue for Q2 2024